CONCUR_2A: CONCUR, figure 2A

CONCUR_2AR Documentation

CONCUR, figure 2A

Description

Kaplan-Meier digitized data from CONCUR, figure 2A (PMID 25981818). A reported sample size of 243 for a primary endpoint of OS in colorectal cancer.

Usage

CONCUR_2A

Format

A data frame of 204 observations and 3 variables:

time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (placebo, regorafenib)

Source

Li J, Qin S, Xu R, et al. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2015; 16: 619–29.

Examples

summary(CONCUR_2A)

kmplot(CONCUR_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.